dimethyl sulfoxide has been researched along with Brain Neoplasms in 23 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The role of N-myc, c-src, and major histocompatibility complex (MHC, H-2 in the mouse) class I antigen gene expressions in dimethyl sulfoxide (DMSO)-induced differentiation and intracerebral tumorigenicity was examined using a mouse MNB85 neuroblastoma cell line." | 3.68 | Role of histocompatibility antigen gene and protooncogene expressions in intracerebral tumorigenicity of mouse neuroblastoma. ( Kärre, K; Kikuchi, H; Klein, G; Ljunggren, HG; Moritake, K; Paine, JT; Yamasaki, T, 1993) |
| "Juvenile angiofibromas are hypervascular tumors that may benefit from preoperative devascularization to reduce intraoperative blood loss." | 2.77 | Preliminary experience with the percutaneous embolization of juvenile angiofibromas using only ethylene-vinyl alcohol copolymer (Onyx) for preoperative devascularization prior to surgical resection. ( Chaudhary, N; Gemmete, JJ; Marentette, LJ; McKean, EL; Pandey, AS; Patel, S; Sullivan, SE, 2012) |
| "The resection of glomus jugulare tumors can be challenging because of their inherent vascularity." | 1.40 | Incidence of cranial nerve palsy after preoperative embolization of glomus jugulare tumors using Onyx. ( Angeli, SI; Aziz-Sultan, MA; Elhammady, MS; Gaynor, BG; Jethanamest, D, 2014) |
| "Intracranial hemangiopericytomas are uncommon but highly vascular dural-based tumors which commonly derive arterial blood supply from both intracranial and extracranial circulations." | 1.39 | Onyx embolization of an intracranial hemangiopericytoma by direct transcranial puncture. ( Ding, D; Kreitel, D; Liu, KC, 2013) |
| "A total of nine pseudoaneurysms treated by Onyx embolization were identified." | 1.39 | Onyx embolization for the endovascular treatment of infectious and traumatic aneurysms involving the cranial and cerebral vasculature. ( Jadhav, AP; Nogueira, RG; Pryor, JC, 2013) |
| "Pretreatment with pyrrolidine dithiocarbamate (PDTC), an inhibitor of the redox sensitive transcription factor NF-kappa B, abrogated the increased expression of p53 protein in response to H(2)O(2), and enhanced cell survival." | 1.31 | p53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress. ( Babbar, P; Chattopadhyay, P; Datta, K; Sinha, S; Srivastava, T, 2002) |
| " The highest bioavailability was obtained with busulphan in DMSO administered i." | 1.30 | Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations. ( Boland, I; Gouyette, A; Hartmann, O; Kalifa, C; Morizet, J; Terrier-Lacombe, MJ; Valteau-Couanet, D; Vassal, G, 1999) |
| "Glioblastoma multiforme is composed of multiple cellular compartments with different morphologic, kinetic, metabolic, vascular, and genetic properties." | 1.26 | Aggressive multimodality therapy based on a multicompartmental model of glioblastoma. ( Broadwell, RD; Ducker, TB; Kaplan, RS; Salcman, M; Samaras, GM, 1982) |
| "Ten patients with brain tumors and indwelling ventricular reservoirs were pretreated with 5% to 10% dimethyl sulfoxide (DMSO) (intravenous, oral, or both) and were then treated with 1." | 1.26 | Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxide. ( Aisner, J; Bachur, NR; Colvin, M; Egorin, MJ; Kaplan, RS; Salcman, M; Wiernik, PH, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (26.09) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Przybylowski, CJ | 1 |
| Zhao, X | 1 |
| Baranoski, JF | 1 |
| Borba Moreira, L | 1 |
| Gandhi, S | 1 |
| Chapple, KM | 1 |
| Almefty, KK | 1 |
| Sanai, N | 1 |
| Ducruet, AF | 1 |
| Albuquerque, FC | 3 |
| Little, AS | 1 |
| Nakaji, P | 2 |
| Day, EK | 1 |
| Zhong, Q | 1 |
| Purow, B | 1 |
| Lazzara, MJ | 1 |
| Ricci, M | 1 |
| Ragonese, F | 1 |
| Gironi, B | 1 |
| Paolantoni, M | 1 |
| Morresi, A | 1 |
| Latterini, L | 1 |
| Fioretti, B | 1 |
| Sassi, P | 1 |
| Gaynor, BG | 1 |
| Elhammady, MS | 1 |
| Jethanamest, D | 1 |
| Angeli, SI | 1 |
| Aziz-Sultan, MA | 1 |
| Ding, D | 1 |
| Kreitel, D | 1 |
| Liu, KC | 1 |
| Park, S | 1 |
| Hwang, SM | 1 |
| Lim, OK | 1 |
| Hwang, C | 1 |
| Lee, DH | 1 |
| Gore, P | 1 |
| Theodore, N | 1 |
| Brasiliense, L | 1 |
| Kim, LJ | 1 |
| Garrett, M | 1 |
| Gonzalez, LF | 1 |
| McDougall, CG | 2 |
| Dashti, SR | 1 |
| Fiorella, D | 1 |
| Spetzler, RF | 1 |
| Beres, E | 1 |
| Gemmete, JJ | 1 |
| Patel, S | 1 |
| Pandey, AS | 1 |
| Sullivan, SE | 1 |
| McKean, EL | 1 |
| Marentette, LJ | 1 |
| Chaudhary, N | 1 |
| Delgado-Goñi, T | 1 |
| Martín-Sitjar, J | 1 |
| Simões, RV | 1 |
| Acosta, M | 1 |
| Lope-Piedrafita, S | 1 |
| Arús, C | 1 |
| Jadhav, AP | 1 |
| Pryor, JC | 1 |
| Nogueira, RG | 1 |
| Jeong, YI | 1 |
| Kim, SH | 1 |
| Jung, TY | 1 |
| Kim, IY | 1 |
| Kang, SS | 1 |
| Jin, YH | 1 |
| Ryu, HH | 1 |
| Sun, HS | 1 |
| Jin, S | 1 |
| Kim, KK | 1 |
| Ahn, KY | 1 |
| Jung, S | 1 |
| Salcman, M | 3 |
| Kaplan, RS | 3 |
| Ducker, TB | 2 |
| Abdo, H | 1 |
| Montgomery, E | 1 |
| Samaras, GM | 1 |
| Broadwell, RD | 1 |
| Neuwelt, EA | 1 |
| Chudinovskaia, NV | 1 |
| Poliakova, GP | 1 |
| Kondakova, LI | 1 |
| Egorin, MJ | 1 |
| Aisner, J | 1 |
| Colvin, M | 1 |
| Wiernik, PH | 1 |
| Bachur, NR | 1 |
| Thomé, S | 1 |
| Craze, J | 1 |
| Mitchell, C | 1 |
| Yamasaki, T | 1 |
| Klein, G | 1 |
| Ljunggren, HG | 1 |
| Kärre, K | 1 |
| Moritake, K | 1 |
| Paine, JT | 1 |
| Kikuchi, H | 1 |
| Boland, I | 1 |
| Vassal, G | 1 |
| Morizet, J | 1 |
| Terrier-Lacombe, MJ | 1 |
| Valteau-Couanet, D | 1 |
| Kalifa, C | 1 |
| Hartmann, O | 1 |
| Gouyette, A | 1 |
| Biçaku, E | 1 |
| Acevedo-Duncan, M | 1 |
| Datta, K | 1 |
| Babbar, P | 1 |
| Srivastava, T | 1 |
| Sinha, S | 1 |
| Chattopadhyay, P | 1 |
| Greig, NH | 1 |
| Sweeney, DJ | 1 |
| Rapoport, SI | 1 |
1 trial available for dimethyl sulfoxide and Brain Neoplasms
| Article | Year |
|---|---|
Preliminary experience with the percutaneous embolization of juvenile angiofibromas using only ethylene-vinyl alcohol copolymer (Onyx) for preoperative devascularization prior to surgical resection.
Topics: Adolescent; Angiofibroma; Brain Neoplasms; Child; Child, Preschool; Dimethyl Sulfoxide; Embolization | 2012 |
22 other studies available for dimethyl sulfoxide and Brain Neoplasms
| Article | Year |
|---|---|
Preoperative embolization versus no embolization for WHO grade I intracranial meningioma: a retrospective matched cohort study.
Topics: Adult; Aged; Brain Neoplasms; Cohort Studies; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; | 2020 |
Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Data Science; Dimethyl Sulfoxide; DNA Repair; Drug Resis | 2021 |
Glioblastoma single-cell microRaman analysis under stress treatments.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dimethyl Sulfoxide; Glioblastoma; Glucose; Humans; Hyd | 2018 |
Incidence of cranial nerve palsy after preoperative embolization of glomus jugulare tumors using Onyx.
Topics: Adult; Aged; Brain Neoplasms; Cerebral Angiography; Cerebral Revascularization; Cranial Nerve Diseas | 2014 |
Onyx embolization of an intracranial hemangiopericytoma by direct transcranial puncture.
Topics: Brain Neoplasms; Cerebral Angiography; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Hemang | 2013 |
Compliant neurovascular balloon catheters may not be compatible with liquid embolic materials: intraprocedural rupture of the protecting balloon during tumor embolization using n-butyl cyanoacrylate and lipiodol mixture.
Topics: Antineoplastic Agents; Balloon Occlusion; Brain Neoplasms; Catheters; Chemoembolization, Therapeutic | 2015 |
The utility of onyx for preoperative embolization of cranial and spinal tumors.
Topics: Adult; Brain Neoplasms; Child; Cohort Studies; Dimethyl Sulfoxide; Embolization, Therapeutic; Female | 2008 |
Preoperative Onyx embolization of a giant cavernous malformation involving the dural sinuses.
Topics: Brain Neoplasms; Child; Cranial Sinuses; Dimethyl Sulfoxide; Embolization, Therapeutic; Hemangioma, | 2009 |
Dimethyl sulfoxide (DMSO) as a potential contrast agent for brain tumors.
Topics: Animals; Brain Neoplasms; Contrast Media; Dimethyl Sulfoxide; Feasibility Studies; Female; Glioblast | 2013 |
Onyx embolization for the endovascular treatment of infectious and traumatic aneurysms involving the cranial and cerebral vasculature.
Topics: Adult; Aged; Aneurysm, False; Aneurysm, Infected; Anterior Cerebral Artery; Brain Injuries; Brain Ne | 2013 |
Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan.
Topics: Adsorption; Antineoplastic Agents; Brain Neoplasms; Carbohydrate Sequence; Cell Line, Tumor; Cell Su | 2006 |
Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma.
Topics: Adolescent; Adult; Age Factors; Aged; Brain Neoplasms; Carmustine; Dimethyl Sulfoxide; Doxorubicin; | 1982 |
Aggressive multimodality therapy based on a multicompartmental model of glioblastoma.
Topics: Brain Neoplasms; Carmustine; Dimethyl Sulfoxide; Drug Therapy, Combination; Glioblastoma; Hot Temper | 1982 |
Therapeutic potential for blood-brain barrier modification in malignant brain tumor.
Topics: Adrenal Cortex Hormones; Animals; Blood-Brain Barrier; Brain Neoplasms; Dimethyl Sulfoxide; Dogs; Do | 1984 |
[Cytological study of the fusion of mouse glioblastoma cells with rat neurinoma cell after the administration of polyethylene glycol combined with dimethyl sulfoxide].
Topics: Animals; Autoradiography; Brain Neoplasms; Cells, Cultured; Cranial Nerve Neoplasms; Dimethyl Sulfox | 1984 |
Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxide.
Topics: Adult; Aged; Brain Neoplasms; Cyclophosphamide; Dimethyl Sulfoxide; Drug Interactions; Drug Therapy, | 1982 |
Dimethylsulphoxide-induced serum hyperosmolality after cryopreserved stem-cell graft.
Topics: Adolescent; Brain Neoplasms; Cryopreservation; Dimethyl Sulfoxide; Germinoma; Hematopoietic Stem Cel | 1994 |
Role of histocompatibility antigen gene and protooncogene expressions in intracerebral tumorigenicity of mouse neuroblastoma.
Topics: Animals; Brain Neoplasms; Dimethyl Sulfoxide; Gene Expression Regulation, Neoplastic; Genes, MHC Cla | 1993 |
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations.
Topics: Administration, Oral; Animals; Biological Availability; Brain Neoplasms; Busulfan; Carboxymethylcell | 1999 |
Ultrastructural study of protein kinase C-betaII localization during the cell cycle of human glioma cells.
Topics: Blotting, Western; Brain Neoplasms; Cell Cycle; Dimethyl Sulfoxide; Glioma; Humans; Immunohistochemi | 2001 |
p53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress.
Topics: Antioxidants; Apoptosis; Brain Neoplasms; Cell Survival; Dimethyl Sulfoxide; Flow Cytometry; Glioma; | 2002 |
Inability of dimethyl sulfoxide to increase brain uptake of water-soluble compounds: implications to chemotherapy for brain tumors.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Cerebrovascular Circulation; Dimethyl Sulfoxid | 1985 |